Clinical Trials Directory

Trials / Completed

CompletedNCT06992297

Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Malaria, endemic in 85 countries, remains a major concern. By 2022, there will be 249 million cases and 608,000 deaths, 94% of them in Africa. In France, 4995 cases of imported malaria were reported in 2021, with 15% of severe forms and a fatality rate of 2.5%. Long-term sequelae, such as kidney failure and neurological disorders, are well documented in children, but few studies have focused on adults. the main objective is to describe and estimate the frequency of long-term sequelae of severe imported malaria treated at our centre. the aim is to compare long-term neurological sequelae between neuromalaria and severe malaria without neurological disorders. In addition, the investigator aim to identify the clinical, radiological and biological factors associated with sequelae in order to improve post-hospitalisation follow-up. Finally, the investigator aim to describe acute complications arising at diagnosis and during hospitalisation.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnairea standardised, structured questionnaire, validated by the department's clinicians, to assess the physical, cognitive and psychological after-effects.

Timeline

Start date
2025-06-17
Primary completion
2025-09-13
Completion
2025-09-13
First posted
2025-05-28
Last updated
2025-12-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06992297. Inclusion in this directory is not an endorsement.